Family with sequence similarity 220 member C, pseudogene (FAM220CP)

Family with sequence similarity 220 member C, pseudogene (FAM220CP), is a human pseudogene, meaning it is a segment of DNA resembling a gene but typically regarded as nonfunctional due to disabling mutations or lack of transcription/translation[1][5]. By definition, pseudogenes like FAM220CP do not produce functional protein products and are not considered conventional drug targets, such as receptors, enzymes, or transporters[1][5]. While most pseudogenes are "genomic fossils," recent research has shown that some pseudogenes may be transcribed into RNA and can exert regulatory effects on their parent genes or the wider transcriptome, such as by acting as microRNA decoys or producing regulatory RNAs[2][4]. However, there is no evidence that FAM220CP is one of these functional pseudogenes, nor any indication of therapeutic relevance, disease modulation, or interaction with known drugs[1][5]. Key Notes: - FAM220CP is not a therapeutic target: it is a pseudogene, lacks a protein product, and is not classified as a receptor, enzyme, transporter, or similar entity. There is no biological or pharmacological evidence to support it being a valid drug target[1][5]. - is_incorrect is true: For most biomedical and pharmacological purposes, querying FAM220CP as a "target" is incorrect. Its status as a pseudogene means it does not fulfill the typical criteria for inclusion in drug target databases. - There may be background interest in the broader field concerning the roles of some transcribed pseudogenes in gene regulation and disease biology[2][4], but FAM220CP is not specifically implicated in such functions based on currently available data[1][5]. This information is based on current gene annotation resources and the scientific consensus on pseudogene biology[1][2][4][5]. If more detailed functional or disease associations become available in the future, these entries may need to be revisited.

Other names

FAM220CP